19-43581614-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001193621.3(PINLYP):c.392C>A(p.Ala131Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000781 in 1,536,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001193621.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PINLYP | NM_001193621.3 | c.392C>A | p.Ala131Glu | missense_variant | 5/6 | ENST00000599207.6 | NP_001180550.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PINLYP | ENST00000599207.6 | c.392C>A | p.Ala131Glu | missense_variant | 5/6 | 5 | NM_001193621.3 | ENSP00000469886 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000144 AC: 2AN: 138746Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 75012
GnomAD4 exome AF: 0.00000578 AC: 8AN: 1384330Hom.: 0 Cov.: 31 AF XY: 0.00000439 AC XY: 3AN XY: 683082
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 26, 2022 | The c.464C>A (p.A155E) alteration is located in exon 5 (coding exon 4) of the PINLYP gene. This alteration results from a C to A substitution at nucleotide position 464, causing the alanine (A) at amino acid position 155 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at